From best to worst: A 2020 winner is now the biggest loser in stock market
Essentially flat year-to-date, a gauge of the sector is the worst-performing in Asia, lagging the region’s benchmark by eight percentage points. It is on track to underperform the MSCI Asia Pacific Index for a third straight month, the longest losing streak in three years.
(Bloomberg)Premium
. Updated: 21 Feb 2021, 09:51 AM IST Bloomberg
A growing expectation of a return to normal for the global economy has caused investors to abandon defensive bets made during the pandemic, such as health care
Share Via
Read Full Story
While technology stocks continue to front Asia’s equity rally, one hot sector from 2020 has fallen to the bottom of the leaderboard: health care.
Published: Feb 16, 2021 By Alex Keown
Pfizer’s COVID-19 vaccine data has once again been threatened by hackers. The alleged theft of intellectual property has been laid at the feet of North Korea’s government.
According to multiple reports, South Korea’s intelligence agency first reported the latest hacking attempts. It is unclear if North Korean operatives were successful in retrieving any data from Pfizer facilities located in Asia. Also unclear is the timeline of when this alleged hacking occurred.
South Korean politician Ha Tae-keung, who is an opposition member of the parliamentary intelligence panel, was the one who made the announcement to news agencies in that country,
Republic of Korea grants USD 10 million to MMV-led consortium to protect children from malaria in the Sahel
Republic of Korea grants USD 10 million to MMV-led consortium to protect children from malaria in the Sahel
SMC IMPACT aims to expand use of seasonal malaria chemoprevention in five African countries.
28 Jan 2021
The Republic of Korea, through its Global Disease Eradication Fund, has awarded USD 10 million in funding to the MMV-led SMC IMPACT project that will explore the expansion of WHO-recommended seasonal malaria chemoprevention (SMC) for children in five countries in the Sahel region of Africa. In two key countries, the project will also train healthcare workers to administer a new artemisinin combination therapy (ACT), pyronaridine-artesunate (Pyramax
SEOUL: The 1,600% jump in a Covid-19 drugmaker loved by retail traders and big gains for electric-vehicle battery suppliers were among the top highlights this year in South Korea’s stock market.
Shin Poong Pharmaceutical Co, which is developing its malaria drug Pyramax as a treatment for the coronavirus, rose more than any other South Korean stock. Its 16-fold gain also topped the 1,573-member MSCI Asia Pacific Index.
With Tesla Inc’s S&P 500-best performance one of the other major stories of 2020, investors sought out EV plays worldwide. Tesla’s top battery supplier LG Chem Ltd climbed 160%, the second-largest contributor to gains in South Korea’s main stock index.
Covid Drug, EV Batteries Were Winning Korean Stock Bets in 2020
Bloomberg 12/30/2020
The 1,600% jump in a Covid-19 drugmaker loved by retail traders and big gains for electric-vehicle battery suppliers were among the top highlights this year in South Korea’s stock market.
Shin Poong Pharmaceutical Co., which is developing its malaria drug Pyramax as a treatment for the coronavirus, rose more than any other Korean stock. Its 16-fold gain also topped the 1,573-member MSCI Asia Pacific Index.
With Tesla Inc.’s S&P 500-best performance one of the other major stories of 2020, investors sought out EV plays worldwide. Tesla’s top battery supplier LG Chem Ltd. climbed 160%, the second-largest contributor to gains in South Korea’s main stock index.